MiR-32-5p aggravates intestinal epithelial cell injury in pediatric enteritis induced by Helicobacter pylori

Jing Feng1, Jian Guo2, Jun-Ping Wang3

  • 1Institute of Loess Plateau, Shanxi University, Taiyuan 030006, Shanxi Province, China.

Insights

Aberrant miR-32-5p expression is increased in pediatric enteritis caused by Helicobacter pylori (H. pylori) infection. This microRNA promotes intestinal cell death and inflammation via the TAK1-p38 pathway, targeting SMAD6.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Microbiology

Background:

  • Pediatric enteritis, a common digestive issue in children, can be caused by Helicobacter pylori (H. pylori) infection.
  • MicroRNAs (miRNAs) show altered expression in H. pylori-related gastrointestinal diseases.
  • A significant increase in miR-32-5p was observed in H. pylori-induced pediatric enteritis, but its role remained unclear.

Purpose of the Study:

  • To elucidate the function of dysregulated miR-32-5p in pediatric enteritis associated with H. pylori.
  • To investigate the molecular mechanisms underlying miR-32-5p's role in H. pylori infection of intestinal cells.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) to measure miR-32-5p expression.
  • Cell Counting Kit-8 assay and flow cytometry to assess cell viability and apoptosis.
  • Bioinformatic prediction (TargetScanHuman) and luciferase assays to identify miR-32-5p targets.
  • Molecular biology techniques to explore downstream signaling pathways.

Main Results:

  • miR-32-5p was significantly upregulated in the serum of children with H. pylori-induced enteritis.
  • H. pylori infection increased intestinal epithelial cell apoptosis and miR-32-5p levels.
  • Overexpression of miR-32-5p exacerbated apoptosis and inflammatory cytokine release.
  • SMAD6 was identified as a direct target of miR-32-5p, and its overexpression partially mitigated H. pylori-induced cell damage.
  • The miR-32-5p/SMAD6 axis was found to mediate H. pylori-induced apoptosis via the TAK1-p38 pathway.

Conclusions:

  • Aberrant miR-32-5p expression plays a critical role in H. pylori-related pediatric enteritis.
  • The TAK1-p38 signaling pathway is implicated in the pathogenesis of H. pylori-induced enteritis involving miR-32-5p.
Abstract

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.0K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.0K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
694